The importance of initial daily administration of interferon alpha for the eradication of hepatitis C virus in patients with chronic hepatitis C: A multicenter randomized trial

Hepato-Gastroenterology

Volumn 45, Issue 22, 1998, Pages 1045-1055

  Nakamura, Hideji ^a   Ito, Hiroaki ^a   Kimura, Yoshihiro ^a,b   Takeda, Akira ^a   Ogawa, Hiroyuki ^a   Kanazawa, Sumie ^a   Kuroda, Toshifumi ^a   Inada, Masahiko ^a   Harada, Hiroshi ^a,c   Kishimoto, Tadamitsu ^a   Zenda, Sadao ^a,b   Terabayashi, Minoru ^a,c   Saeki, Kou ^a,d   Wada, Masami ^a,e   Igarashi, Atsushi ^a,e   Uemiya, Masanao ^a,f   Kobayashi, Yasushi ^a,g   Hayashi, Eijiro ^a,h  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^c Saiseikai Tondabayashi Hospital   (Japan)

^d Second Police Hospital   (Japan)

^e Osaka Teishin Hospital   (Japan)

^f Nissei Hospital   (Japan)

^g OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^h OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

Author keywords

Chronic hepatitis C; Natural interferon treatment

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; VIRUS RNA;

ADULT; ALOPECIA; ARTICLE; CHRONIC HEPATITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REMISSION; RHEUMATOID ARTHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION; THYROIDITIS;

ALANINE TRANSAMINASE; DNA, VIRAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 15444343355     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hoofnagle JM, Mullan KD, Jones DB, Rustgi V, DiBisceglie A, Peters M, Waggoner JG, et al.: Treatment of chronic non-A, non-B hepatitis with recombinant human alfa interferon. A preliminary report. N Engl J Med. 1986; 315: 1575-8.
2. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244: 359-62.
3. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L: Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology. 1991; 14: 381-8.
4. Picciotto A, Callea F, Varagonna G, Bardellini E, Borzone S, DeConca V, Vallarino E, et al.: Lymphoblastoid interferon therapy in chronic hepatitis C: Biochemical, virological and histological evaluation of two different doses. Liver. 1995; 15: 20-4.
5. Angelini G, Sgarbi D, Colombari R, Bezzi A, Castagnini A, DeBerardinis F, Conti A, et al.: Alpha-interferon treatment of chronic hepatitis C: A controlled, multicenter, prospective study. Digestion. 1995; 56: 199-203.
6. Garson JA, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, et al.: Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. J Med Virol. 1995; 45: 348-53.
7. Yoshioka K, Higashi Y, Yamada M, Aiyama T, Takayanagi M, Tanaka K, Okumura A, et al.: Predictive factors in the response to interferon therapy in chronic hepatitis C. Liver. 1995; 15: 57-62.
8. Roffi L, Mekls GC, Antonelli G, Bellati G, Panizzuti F, Piperno A, Pozzi M, et al.: Breakthrough during recombinant interferon a therapy with chronic hepatitis C virus infection: Prevalence, etiology, and management. Hepatology. 1995; 21: 645-9.
9. Hakozaki Y, Shirahama T, Katou M, Nakagawa K, Oba K, Mitamura K: A controlled study to determine the optimal dose regimen of interferon-α 2b in chronic hepatitis C. Am J Gastroenterol. 1995; 90: 1246-9.
10. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, et al.: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med. 1995; 332: 1457-62.
11. Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, et al.: Ability of prolonged interferon treatment to suppress relapse after cesstion of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial. Hepatology. 1995; 21: 291-7.
12. Bellry S, Smith DG, Bankes P, Harris A, Shyiq R, Black M: High dose interferon α 2b therapy for chronic hepatitis C: An open label study of the response and predictors of response. Am J Gastroenterol. 1995; 90: 259-62.
13. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1: 431-5.
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 1994; 19: 1513-20.
15. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, et al.: The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 1990; 60: 167-77.
16. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al.: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol. 1992; 73: 673-9.
17. Simmonds P, Holmes EC, Cha T-A, Chan S-W, McOmish F, Irvine B, Beall E, et al.: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993; 74: 2391-9.
18. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, et al.: Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol. 1994; 42: 299-305.
19. Hino K, Okuda M, Konishi T, Ishiko H, Okita K: Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig Dis Sci. 1995; 40: 14-20.
20. Cha T-A, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS: At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA. 1992; 89: 7144-8.
21. Bukh J, Purcell RH, Miller RH: At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected world wide. Proc Natl Acad Sci USA. 1993; 90: 8234-8.
22. Bukh J, Purcell RH, Miller RH: Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA. 1994; 91: 8239-43.
23. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, et al.: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 1991; 88: 2451-5.
24. Wang Y, Okamoto H, Tsuda F, Nagayama R, Tao Q-M, Mishiro S: Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol. 1993; 40: 254-60.
25. Hadiwandomo S, Tuda F, Okamoto H, Tokita H, Wang Y, Tanaka T, Miyakawa M, et al.: Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol. 1994; 43: 182-6.
26. Kanai K, Kako M, Okamoto H: HCV genotypes in chronic hepatitis C and response to interferon. Lancet. 1992; 339: 1543.
27. Chemello L, Albert A, Rose K, Simmonds P: Hepatitis C serotype and response to interferon therapy. N Engl J Med. 1994; 330: 143.
28. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, et al.: Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relation to genotypes of hepatitis C virus. Hepatology. 1992; 16: 293-9.
29. Shindo M, Arai K, Sokawa Y. Okuno T: Hepatic C virus RNA as a predictor of a long-term response to interferon-α therapy. Ann Intern Med. 1995; 122: 586-91.
30. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, et al.: Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 1996; 334: 77-81
31. Booth JC, Foster GR, Kumar U, Galassini R, Goldin RD, Brown JL, Thomas HC: Chronic hepatitis C virus infections: Predictive value of genotype and level of viraemia on disease progression and response to interferon α. Gut. 1995; 36: 427-32.
32. Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R: Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: Effect of alpha-interferon therapy. J Hepatol. 1995; 22: 22-6.
33. Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim K-S, Carol-Shieh YS, Taylor B, et al.: Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment. Gastroenterol. 1993; 104: 1472-7.